As of January 2025, Tasly Pharmaceutical Group has a market cap of $3.01B. This makes Tasly Pharmaceutical Group the world's 3879th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.27B | -6.64% |
2023 | $3.50B | 58.18% |
2022 | $2.21B | -32.11% |
2021 | $3.26B | 7.17% |
2020 | $3.04B | -4.09% |
2019 | $3.17B | -19.69% |
2018 | $3.95B | -24.45% |
2017 | $5.22B | -14.24% |
2016 | $6.09B | 1.39% |
2015 | $6.01B | -0.44% |
2014 | $6.03B | -4.17% |
2013 | $6.30B | 55.20% |
2012 | $4.06B | 31.78% |
2011 | $3.08B | 2.90% |
2010 | $2.99B | 81.96% |
2009 | $1.64B | 81.08% |
2008 | $908.10M | -43.80% |
2007 | $1.62B | 128.38% |
2006 | $707.50M | 56.39% |
2005 | $452.40M | 7.52% |
2004 | $420.76M | 26.39% |
2003 | $332.91M | -21.65% |
2002 | $424.91M | - |